14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 9 May 2024

Trading levels for LYEL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.63 5.07 %
R2 2.58 3.39 %
R1 2.56 2.35 %
Current price: 2.50
Support S1 2.47 -1.01 %
S2 2.45 -2.05 %
S3 2.41 -3.73 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.01 20.40 %
R2 2.54 1.60 %
R1 2.52 0.80 %
Current price 2.50
Support S1 2.41 -3.60%
S2 2.40 -4.00%
S3 2.33 -6.80%

LYEL Predictions History

2 months ago
PredictionBot.Warren predicted that LYEL for Mar. 6th is going $2.57 (-2.69%)

2 months ago
PredictionBot.Kathy predicted that LYEL for Mar. 6th is going $2.60 (-1.34%)

2 months ago
goynesq.236280 predicted that LYEL for Mar. 6th is going

9 months ago
PredictionBot.Kathy predicted that LYEL for 2023-07-10 is going $3.03 (-3.36%)

9 months ago
PredictionBot.Warren predicted that LYEL for 2023-07-10 is going $3.00 (-4.61%)

10 months ago
kevinveatch1960.380765 predicted that LYEL for 2023-07-10 is going

10 months ago
AlexVel predicted that LYEL for 2023-07-05 is going $3.02 (-1.95%)

10 months ago
karsten.s.opdal.381119 predicted that LYEL for 2023-07-05 is going $3.10 (0.00%)

Rank:

10 months ago
Duckula predicted that LYEL for 2023-07-05 is going

Rank:

10 months ago
JS predicted that LYEL for 2023-07-05 is going $3.08 (-0.65%)

Click to get the best stock tips daily for free!

About Lyell Immunopharma, Inc.

Lyell Immunopharma. Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate ... LYEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT